Avadel clinical trials
Acquired by Alkermes, Inc., Feb 12, 2026 · source ↗
The registry lists 4 studies whose lead sponsor is Avadel. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 11, 2026.
Before and after it joined Alkermes, Inc.
- First submitted before Avadel became part of Alkermes, Inc.
- 4
- First submitted after Avadel became part of Alkermes, Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Avadel4 studies
Something wrong with this grouping? Tell us on the Alkermes, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Alkermes, Inc. studies →
- Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)CompletedNCT06525077Phase 3
Sponsor listed in the registry: Avadel · First submitted before Avadel became part of Alkermes, Inc.
- Observational Study of LUMRYZ in NarcolepsyCompletedNCT06792708
Sponsor listed in the registry: Avadel · First submitted before Avadel became part of Alkermes, Inc.
- An Open Label Study of FT218 in Subjects With NarcolepsyCompletedNCT04451668Phase 3
Sponsor listed in the registry: Avadel · First submitted before Avadel became part of Alkermes, Inc.
- Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in NarcolepsyCompletedNCT02720744Phase 3
Sponsor listed in the registry: Avadel · First submitted before Avadel became part of Alkermes, Inc.